鼻旁窦与鼻腔癌:美国镭学会适用标准系统评价与执行摘要
针对鼻旁窦与鼻腔(PNS/NC)肿瘤这一罕见且组织学多样的疾病,美国镭学会通过系统评价39项成人根治性治疗研究(PRISMA方法)并结合改良Delphi流程形成适用标准共识。共识强烈支持早期病变行原发手术、局部晚期伴轻微眶周脂肪侵犯的特定处理及诱导化疗后反应导向局部治疗;对淋巴结处理与辅助质子治疗共识较弱。
要点
- 早期PNS/NC肿瘤原发手术获强烈共识推荐。
- 局部晚期伴轻微眶周脂肪侵犯的处理及诱导化疗后反应导向局部治疗获强烈共识。
- 淋巴结处理与辅助质子治疗的共识较弱。
核心结论
- 系统评价与适用标准共识为PNS/NC肿瘤这一具有挑战性的疾病谱提供临床指导。
研究设计与样本
- 由图书馆员协助检索文献,纳入39项接受根治性治疗的成人PNS/NC肿瘤研究,按PRISMA方法报告,并采用改良Delphi流程形成共识。
主要发现
- 早期病变原发手术、局部晚期伴轻微眶周脂肪侵犯的处理方式及诱导化疗后反应导向局部治疗均获强烈共识。
- 淋巴结处理与辅助质子治疗的共识较弱。
关键数值与推荐
- 早期病变原发手术获强烈共识推荐。
- 局部晚期伴轻微眶周脂肪侵犯的处理获强烈共识推荐。
- 诱导化疗后反应导向局部治疗获强烈共识推荐。
- 淋巴结处理与辅助质子治疗的共识较弱。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- PNS/NC肿瘤的罕见性与多样性限制了指导治疗的随机III期试验。
- 临床决策常基于有限的回顾性证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tumors of the paranasal sinus and nasal cavity (PNS/NC) are rare and exhibit diverse histology, anatomic subsite, and malignant potential. Early-stage disease is typically managed with surgery, and locally advanced disease is treated with a combination of surgery, radiotherapy, and chemotherapy. Clinical decision-making is commonly guided by limited retrospective evidence. To address this limitation, we performed a systematic review to inform evidence-based consensus for the management of common clinical scenarios, including the potential roles of radiation and systemic therapy to promote structural preservation, elective neck management, and radiation technique considerations. A librarian-mediated literature search identified 39 studies of adult patients with PNS/NC tumors treated with curative intent that met the study inclusion criteria. Search results were reported using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) methodology. A modified-Delphi process was used to guide consensus for the appropriate use of various management strategies. Strong consensus existed for the appropriateness of primary surgery for early-stage disease, approaches to locally advanced disease with minimal periorbital fat invasion, and the use of induction chemotherapy with response-directed local therapy. Consensus regarding nodal treatment and the use of proton therapy in the adjuvant setting was less robust. The rarity and diversity of PNS/NC tumors limit randomized phase III trials to guide management. As such, this systematic review and appropriate-use consensus statements provide clinical guidance for the management of this challenging disease spectrum.
引用
- Witek ME, Ward MC, Bakst R, et al. Paranasal Sinus and Nasal Cavity Cancers: Systematic Review and Executive Summary of the American Radium Society Appropriate Use Criteria. Head Neck. 2025. PMID: 40344605. doi:10.1002/hed.28177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。